Synthesis and biological evaluation of some novel 4′-thio-L-ribonucleosides with modified nucleobase moieties

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 11, 2003, Pages 1849-1852

  Pejanović, Vjera ^a,c   Stokić, Zdenka ^a   Stojanović, Biljana ^a   Piperski, Vesna ^a   Popsavin, Mirjana ^b   Popsavin, Velimir ^b  

^a Galenika AD   (Yugoslavia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c Hemofarm Group

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5 TETRA O ACETYL 4 THIO BETA LEVO RIBOFURANOSE; FLUCYTOSINE; FLUOROURACIL; METHYL ALPHA DEXTRO LYXOPYRANOSIDE; NUCLEIC ACID BASE; NUCLEOSIDE DERIVATIVE; RIBONUCLEOSIDE; TIOGUANINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CHEMICAL PROCEDURES; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; EVALUATION; HUMAN; HUMAN CELL; IC 50; INHIBITION KINETICS; NONHUMAN; SEQUENCE ANALYSIS;

EID: 0037718419     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00289-0     Document Type: Article

References (29)

1. (a) Dyson M.R., Coe P.L., Walker R.T. J. Med. Chem. 34:1991;2782
2. (b) Secrist J.A. III, Tiwari K.N., Riordan J.M., Montgomery J.A. J. Med. Chem. 34:1991;2361.
3. (a) Naka T., Minakawa N., Abe H., Kaga D., Matsuda A. J. Am. Chem. Soc. 122:2000;7233
4. (b) Clement M.A., Berger S.H. Med. Chem. Res. 2:1992;154
5. (c) Bellon L., Barascut J.-L., Imbach J.-L. Nucleosides Nucleotides. 11:1992;1467
6. (d) Bobek M., Bloch A., Parthasarathy R., Whistler R.L. J. Med. Chem. 18:1975;784
7. (e) Ototani N., Whistler R.L. J. Med. Chem. 17:1974;535
8. (f) Bobek M., Whistler R.L., Bloch A. J. Med. Chem. 13:1970;411.
9. Satoh H., Yoshimura Y., Sakata S., Miura S., Machida H. Bioorg. Med. Chem. Lett. 8:1998;989. and references therein.
10. (a). For examples, see: Griffon J.-F., Mathé C., Faraj A., Aubertin A.-M., De Clercq E., Balzarini J., Sommadossi J.-P., Gosselin G. Eur. J. Med. Chem. 36:2001;447 (b) Lin T.-S., Luo M.-Z., Liu M.C., Pai S.B., Dutschman G.E., Cheng Y.-C. J. Med. Chem. 37:1994;798 (c) Mansuri M.M., Farina V., Starrett J.E. Jr., Benigni D.A., Brankovan V., Martin J.C. Bioorg. Med. Chem. Lett. 1:1991;65.
11. (a). For examples, see: Griffon J.-F., Mathé C., Faraj A., Aubertin A.-M., De Clercq E., Balzarini J., Sommadossi J.-P., Gosselin G. Eur. J. Med. Chem. 36:2001;447 (b) Lin T.-S., Luo M.-Z., Liu M.C., Pai S.B., Dutschman G.E., Cheng Y.-C. J. Med. Chem. 37:1994;798 (c) Mansuri M.M., Farina V., Starrett J.E. Jr., Benigni D.A., Brankovan V., Martin J.C. Bioorg. Med. Chem. Lett. 1:1991;65.
12. (a). For examples, see: Griffon J.-F., Mathé C., Faraj A., Aubertin A.-M., De Clercq E., Balzarini J., Sommadossi J.-P., Gosselin G. Eur. J. Med. Chem. 36:2001;447 (b) Lin T.-S., Luo M.-Z., Liu M.C., Pai S.B., Dutschman G.E., Cheng Y.-C. J. Med. Chem. 37:1994;798 (c) Mansuri M.M., Farina V., Starrett J.E. Jr., Benigni D.A., Brankovan V., Martin J.C. Bioorg. Med. Chem. Lett. 1:1991;65.
13. Heitner H.I., Lippard S.J., Sunshine H.R. J. Am. Chem. Soc. 94:1972;8936.
14. Reist E.J., Gueffroy D.E., Goodman L. J. Am. Chem. Soc. 86:1964;5658.
15. Popsavin V., Grabez S., Stojanović B., Popsavin M., Pejanović V., Miljković D. Carbohydr. Res. 321:1999;110.
16. The by-product 12 was presumably formed from the thioacetate 11 by a competitive S-O acetyl migration process. For a related example see: Heap J.M., Owen L.N. J. Chem. Soc. (C). 707:1970.
17. Bobek M., Whistler R.L. Methods Carbohydr. Chem. 6:1972;292.
18. ++H).
19. Vorbrüggen H., Krollikiewics K., Bennua B. Chem. Ber. 114:1981;1234.
20. 4,F=33.9 Hz, C-4).
21. 4S: 278.0611.
22. ++1).
23. ++1).
24. Chu C.K., El-Kabbani F.M., Thompson B.B. Nucleosides Nucleotides. 3:1984;1.
25. 2. The tested compounds were added to the cells seeded in triplicates in the concentration range of 0.78-100 μM and incubated for 72 h.
26. For recent reviews see: Chen S.H. Curr. Med. Chem. 9:2002;899 Gumina G., Song G.Y., Chu C.K. FEMS Microbiol. Lett. 202:2001;9 Maury G. Antivir. Chem. Chemoth. 11:2000;165 Wang P., Hong J.H., Cooperwood J.S., Chu C.K. Antiviral Res. 40:1998;19.
27. For recent reviews see: Chen S.H. Curr. Med. Chem. 9:2002;899 Gumina G., Song G.Y., Chu C.K. FEMS Microbiol. Lett. 202:2001;9 Maury G. Antivir. Chem. Chemoth. 11:2000;165 Wang P., Hong J.H., Cooperwood J.S., Chu C.K. Antiviral Res. 40:1998;19.
28. For recent reviews see: Chen S.H. Curr. Med. Chem. 9:2002;899 Gumina G., Song G.Y., Chu C.K. FEMS Microbiol. Lett. 202:2001;9 Maury G. Antivir. Chem. Chemoth. 11:2000;165 Wang P., Hong J.H., Cooperwood J.S., Chu C.K. Antiviral Res. 40:1998;19.
29. For recent reviews see: Chen S.H. Curr. Med. Chem. 9:2002;899 Gumina G., Song G.Y., Chu C.K. FEMS Microbiol. Lett. 202:2001;9 Maury G. Antivir. Chem. Chemoth. 11:2000;165 Wang P., Hong J.H., Cooperwood J.S., Chu C.K. Antiviral Res. 40:1998;19.